Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Neuraxis cash
Cash and short-term investments held at the end of each period.
Neuraxis's cash was $8.32M at Jun 30, 2026. For fiscal 2025 it was $4.97M, up 34.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.97M | +34.3% |
| FY2024 | Dec 31, 2024 | $3.70M | +4605.8% |
| FY2023 | Dec 31, 2023 | $78.56K | -69.0% |
| FY2022 | Dec 31, 2022 | $253.70K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.32M | +39.0% |
| Q1 FY2026 | Mar 31, 2026 | $7.08M | +253.0% |
| Q4 FY2025 | Dec 31, 2025 | $4.97M | +34.3% |
| Q3 FY2025 | Sep 30, 2025 | $4.38M | +1577.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.99M | +239.2% |
| Q1 FY2025 | Mar 31, 2025 | $2.01M | +2353.0% |
| Q4 FY2024 | Dec 31, 2024 | $3.70M | +4605.8% |
| Q3 FY2024 | Sep 30, 2024 | $260.89K | -65.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.77M | +3331.7% |
| Q1 FY2024 | Mar 31, 2024 | $81.75K | -67.8% |
| Q4 FY2023 | Dec 31, 2023 | $78.56K | – |
| Q3 FY2023 | Sep 30, 2023 | $761.25K | – |
| Q2 FY2023 | Jun 30, 2023 | $51.44K | – |
| Q4 FY2022 | Dec 31, 2022 | $253.70K | – |
See a number that looks wrong?